Artificial Intelligence

Bionano's 2026 virtual event will showcase how Optical Genome Mapping is revolutionizing cancer and genetic disease research and paving a path to clinical use.

A leading fintech company's Q1 charity provides food and a refrigerated truck, tackling growing food insecurity with strategic local partnerships.

Backed by a proven billion-dollar impact model, 14 new startups are using AI, neuroscience, and philanthropy to revolutionize mental healthcare.

A Chinese biotech's novel nasal spray flu vaccine enters trials. Its unique design could finally make it safe for the elderly and expand global access.

A new initiative backed by the Japanese government aims to transform the nation's world-class scientific research into globally competitive biotech companies.

New AI-powered 'Spend Control' platform with deep ERP integration aims to transform chaotic contract management into a strategic financial advantage for CFOs.

As it marks its 40th year, the legal finance giant's impressive 3.0x return on capital highlights the growing appeal of legal assets as a stable asset class.

A landmark deal will see Takeda use Iambic's AI platform to slash drug development timelines and fast-track new medicines for cancer and other diseases.

From its unique seat at the World Government Summit, CanSinoBIO unveils its next-gen vaccine pipeline and global strategy to fight humanity's oldest diseases.

After a year-long restructuring, SVCV launches asset manager NextRock to acquire 100 companies and build a cross-industry empire from finance to fashion.

CAEVES Intelligent Deep Storage™ is now on the Microsoft Marketplace, promising to unlock historical data for AI and analytics while slashing costs.

With five conferences in its sights, Voyager Therapeutics is making a major push to win over investors ahead of a pivotal year for its neurological pipeline.

Melius Research elevates 'AI eating software' visionary Ben Reitzes to Partner, signaling a major bet on tech-driven expansion for the independent firm.

A new report reveals AI-themed ads failed to connect with viewers, while heartfelt, human-centric stories from brands like the NFL and Budweiser won the night.

Fresh off its Nasdaq debut, adtech firm EVA Live is betting on its new NeuroServer AI, shelving a stock sale and eyeing a buyback to fuel growth.

A £500,000 philanthropic investment fuels five pioneering research projects at Oxford, aiming to unlock new treatments for a devastating rare disease.

With a new flexible, founder-first model, Activation Capital's Frontier BioHealth program aims to bridge the commercialization gap for life sciences startups.

At AFCEA West, One Stop Systems and Tauro will demo a new AI-ready sensor hub designed to accelerate decision-making in demanding defense environments.

Computational chemistry firm Evogene adds world-renowned experts to guide its ChemPass AI™, aiming to accelerate drug and ag-chemical innovation.

IN8bio promotes Kate Rochlin to President, signaling a strategic push to advance its promising gamma-delta T cell pipeline amid a challenging market.